ABT vs. NOVO-B.CO
Compare and contrast key facts about Abbott Laboratories (ABT) and Novo Nordisk A/S (NOVO-B.CO).
Performance
ABT vs. NOVO-B.CO - Performance Comparison
Loading graphics...
ABT vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | -17.64% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 29.06% | 52.03% |
NOVO-B.CO Novo Nordisk A/S | -27.56% | -39.54% | -15.04% | 55.49% | 22.06% | 62.19% | 24.39% | 29.71% | -12.97% | 54.02% |
Different Trading Currencies
ABT is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, ABT achieves a -17.64% return, which is significantly higher than NOVO-B.CO's -27.56% return. Over the past 10 years, ABT has outperformed NOVO-B.CO with an annualized return of 11.37%, while NOVO-B.CO has yielded a comparatively lower 5.15% annualized return.
ABT
- 1D
- 0.78%
- 1M
- -11.76%
- YTD
- -17.64%
- 6M
- -22.62%
- 1Y
- -21.15%
- 3Y*
- 2.45%
- 5Y*
- -1.11%
- 10Y*
- 11.37%
NOVO-B.CO
- 1D
- 1.05%
- 1M
- -1.52%
- YTD
- -27.56%
- 6M
- -31.59%
- 1Y
- -45.06%
- 3Y*
- -21.16%
- 5Y*
- 3.25%
- 10Y*
- 5.15%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABT vs. NOVO-B.CO — Risk / Return Rank
ABT
NOVO-B.CO
ABT vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABT | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.92 | -0.80 | -0.12 |
Sortino ratioReturn per unit of downside risk | -1.12 | -0.95 | -0.17 |
Omega ratioGain probability vs. loss probability | 0.84 | 0.87 | -0.03 |
Calmar ratioReturn relative to maximum drawdown | -0.80 | -0.86 | +0.06 |
Martin ratioReturn relative to average drawdown | -2.02 | -1.50 | -0.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ABT | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.92 | -0.80 | -0.12 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.08 | -0.13 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.48 | 0.16 | +0.33 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.41 | 0.43 | -0.02 |
Correlation
The correlation between ABT and NOVO-B.CO is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
ABT vs. NOVO-B.CO - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 2.34%, less than NOVO-B.CO's 5.07% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.34% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
NOVO-B.CO Novo Nordisk A/S | 5.07% | 3.58% | 1.59% | 1.01% | 1.19% | 1.27% | 2.02% | 2.11% | 2.64% | 2.27% | 3.69% | 1.25% |
Drawdowns
ABT vs. NOVO-B.CO - Drawdown Comparison
The maximum ABT drawdown since its inception was -55.57%, smaller than the maximum NOVO-B.CO drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for ABT and NOVO-B.CO.
Loading graphics...
Drawdown Indicators
| ABT | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.57% | -76.75% | +21.18% |
Max Drawdown (1Y)Largest decline over 1 year | -25.18% | -54.94% | +29.76% |
Max Drawdown (5Y)Largest decline over 5 years | -33.88% | -76.75% | +42.87% |
Max Drawdown (10Y)Largest decline over 10 years | -33.88% | -76.75% | +42.87% |
Current DrawdownCurrent decline from peak | -25.41% | -76.01% | +50.60% |
Average DrawdownAverage peak-to-trough decline | -14.29% | -15.79% | +1.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.94% | 31.97% | -22.03% |
Volatility
ABT vs. NOVO-B.CO - Volatility Comparison
The current volatility for Abbott Laboratories (ABT) is 5.95%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 9.89%. This indicates that ABT experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ABT | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.95% | 9.89% | -3.94% |
Volatility (6M)Calculated over the trailing 6-month period | 16.83% | 41.63% | -24.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.14% | 56.93% | -33.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.98% | 39.05% | -17.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.57% | 33.04% | -9.47% |
Financials
ABT vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities